作者: Matthew R Kudelka , Ghassan K Abou-Alfa , Eileen M O’Reilly , Michael B Foote , Bhawna Sirohi
DOI:
关键词:
摘要: BackgroundLess than two percent of pancreatic neuroendocrine tumors (NETs) produce serotonin. Serotonin can cause carcinoid syndrome and less commonly carcinoid heart disease (CHD). CHD is associated with increased mortality and requires a more aggressive approach. Here we present a rare case of a serotonin-producing pancreatic NET complicated by CHD at presentation and discuss timing of systemic therapy, liver-directed therapy, and heart failure management.